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For over four decades the thoracic aortic ring model has become one of the most
widely used methods to study vascular reactivity and electromechanical coupling. A
question that is rarely asked, however, is what function does a drug-mediated relaxation
(or contraction) in this model serve in the intact system? The physiological significance of
adenosine relaxation in rings isolated from large elastic conduit arteries from a wide range
of species remains largely unknown. We propose that adenosine relaxation increases
aortic compliance in acute stress states and facilitates ventricular-arterial (VA) coupling,
and thereby links compliance and coronary artery perfusion to myocardial energy
metabolism. In 1963 Berne argued that adenosine acts as a local negative feedback
regulator between oxygen supply and demand in the heart during hypoxic/ischemic
stress. The adenosine VA coupling hypothesis extends and enhances Berne’s “adenosine
hypothesis” from a local regulatory scheme in the heart to include conduit arterial
function. In multicellular organisms, evolution may have selected adenosine, nitric oxide,
and other vascular mediators, to modulate VA coupling for optimal transfer of oxygen
(and nutrients) from the lung, heart, large conduit arteries, arterioles and capillaries
to respiring mitochondria. Finally, a discussion of the potential clinical significance of
adenosine modulation of VA coupling is extended to vascular aging and disease,
including hypertension, diabetes, obesity, coronary artery disease and heart failure.
Keywords: rat aorta, adenosine, relaxation, ventricular-arterial coupling, vasodilation, compliance
From these studies emerged the idea that a labile substance was released from the heart (presumably
from themyocardial cells) when the oxygen supply became inadequate for the oxygen needs of the heart,
and the labile substance dilated the coronary-resistance vessels, thereby increasing coronary blood flow
and restoring the balance between oxygen need and supply.
Robert M. Berne (originator of the “Adenosine Hypothesis”). Quoted from (Berne, 1998), p14
BACKGROUND
Berne’s “labile substance” was adenosine, and the same “adenine compound” was shown to
influence heart function some 30 years earlier by Drury and Szent-Gyorgyi (1929). Today, we know
adenosine as a naturally occurring, multi-functional, endogenous purine nucleoside that plays a
key role in the cardiovascular system by activating adenosine receptor subtypes on constituent
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cardiac and vascular cells: A1, A2A, A2B, and A3 (Vinten-
Johansen et al., 1999; Fredholm et al., 2001; Linden, 2001;
Jacobson and Gao, 2006; Leal et al., 2008; Headrick et al., 2013).
Adenosine also regulates cardiovascular function indirectly
from its effects on central and peripheral nervous systems
(Minic et al., 2015). Adenosine is produced by most cells
in the body in response to metabolic stress or injury and
also assists in the modulation of the early inflammatory
and innate immune responses (Hasko and Cronstein, 2004;
Headrick et al., 2013). Adenosine has been shown to inhibit the
release of proinflammatory cytokines TNF-α, IL-6, and IL-12,
and stimulate the release of anti-inflammatory cytokines IL-8,
IL-10, and VEGF by macrophages, and there is accumulating
evidence that it promotes angiogenesis, tissue remodeling
and wound healing (Hasko and Cronstein, 2004; Chan
and Cronstein, 2010; Ernens et al., 2015; Vecchio et al.,
2017). The focus of this perspective is on a new role for
adenosine as a possible “aortic compliance regulator” that links
myocardial perfusion to arterial compliance in the cardiovascular
system.
THE ADENOSINE HYPOTHESIS:
METABOLIC CONTROL OF CORONARY
BLOOD FLOW
Since Berne first proposed the “adenosine hypothesis” over
50 years ago (Berne, 1963, 1980), there has been much
controversy about its wider importance to the regulation
of coronary flow in heart, and other organs in normal
and pathological states (Collis, 1989; Feliciano and Henning,
1999; Feigl, 2004). Berne originally proposed that during
hypoxia (or ischemia) adenosine was a potent local negative
feedback regulator between myocardial oxygen supply and
oxygen demand. As myocardial pO2 decreases during hypoxia
(i.e., increased oxygen demand), adenosine is formed in the
myocyte from the breakdown of adenosine 5′ monophosphate
(AMP), diffuses across the interstitial space to the coronary
artery and causes vasodilation (i.e., increased oxygen supply)
(Figure 1). Berne’s hypothesis was bold and far-reaching
because during the 1960s there was little or no knowledge
on the mechanisms of how adenosine dilated the vessel
wall.
In the late 1970s the “adenosine hypothesis” entered
a new era when adenosine receptors were identified and
functionally characterized (Fredholm et al., 2001; Linden,
2001; Jacobson and Gao, 2006). A decade later Headrick and
Berne showed that adenosine dilation of guinea-pig aorta
involved activation of the adenosine A2 receptor subtype,
with 30% relaxation being derived from the endothelium and
70% from underlying smooth muscle (Headrick and Berne,
1990). Today, coronary vasodilation involves principally the
activation of A2A or A2B receptors depending upon animal
species, and a complex crosstalk between A1 and A3 receptor
subtypes that remain poorly defined (Headrick et al., 2013).
Notwithstanding the advances in the 1990s, in a memoir
written by Berne at the turn of the century, he jokingly wrote
about the ongoing controversies surrounding his “adenosine
hypothesis”:
“But the worst blow was when I was skiing with Larry Rowell and
Eric Feigl and some of their postdocs on one of my many visits to
Seattle. As I lost control on a steep slope and proceeded to crash, a
voice rang out from one of the postdocs on the ski-lift as he viewed
the carnage . . . There goes the adenosine hypothesis.”
(Berne, 1998, p. 14).
Since that time increasing support has accrued for the concept
that adenosine acts as a “negative feedback regulator” in
most tissues during hypoxia/ischemia, including skeletal
muscle and brain (Feigl, 2004). In addition, adenosine
has many other important cellular protective properties
following hypoxia/ischemia or injury (see Background above).
More recently, adenosine has been identified as one of the
self-preservation signals of ischemic preconditioning and
post-conditioning in the heart and most organs of the body,
which appears to involve a memory-like function leading to
the activation of multiple survival kinase pathways (Vinten-
Johansen et al., 2007; Headrick et al., 2013). Notwithstanding
the evolutionary importance of adenosine to flow regulation and
energy metabolism, it must be acknowledged that adenosine
is only one of many vascular modulators that link blood
flow supply to metabolic demand. Other modulators include
membrane potential, nitric oxide (NO), KATP channel openers,
catecholamines, endothelins, prostanoids, opioids, reactive
oxygen species, pO2, pCO2, and pH (Furchgott, 1983; Wilkinson
et al., 2002; Duncker and Bache, 2008; Bellien et al., 2010; Marti
et al., 2012; Quillon et al., 2015; Félétou, 2016; Behringer, 2017).
PHYSIOLOGICAL FUNCTIONS OF THE
LARGE ELASTIC AORTA
A large number of experimental studies spanning over
three decades have demonstrated that adenosine is a potent
vasorelaxant of thoracic aortic rings from a wide range of species
(Heistad et al., 1978; Lewis and Hourani, 1997; Ray andMarshall,
2006; Mustafa et al., 2009; Ponnoth et al., 2009; Headrick et al.,
2013; Arsyad and Dobson, 2016). An important question that
is rarely asked, however, is how does relaxation of an isolated
aortic ring translate into function in the intact system? And
why has adenosine signaling been selected and highly conserved
in the thoracic aorta? To help answer these questions, we will
first consider the functional differences between the aorta and
smaller muscular arterioles. The aorta operates as a biological
“windkessel” or buffering reservoir that stores a portion (∼10%)
of kinetic energy from stroke work during systole, and transfers
it during diastole to maintain a relative constant pressure and
flow to the periphery (London, 2005; Erbel and Eggebrecht,
2006; Steppan et al., 2011). Thus the aorta is not a resistance
vessel constantly dilating and relaxing, like the smaller muscular
coronary arteries or peripheral arterioles, to meet the oxygen
demands of a tissue. The aorta and other conduit arteries
(carotid, iliac, pulmonary trunk and brachiocephalic trunk), are
highly elastic vessels that dampen the pulsatile flow generated
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FIGURE 1 | Schematic of Berne’s “adenosine hypothesis,” which proposes that myocardial hypoxia leads to the breakdown of adenine nucleotides and formation of
adenosine, which “diffuses out of the cell and reaches the coronary arterioles via the interstitial fluid and produces arteriolar dilation” (Berne, 1963). As blood flow
increases and metabolic energy demand is met, adenine nucleotides decrease leading to decreases in interstitial adenosine “by washout and enzymatic destruction”
(Berne, 1963). In this way, adenosine serves as a local negative feedback regulator of oxygen supply and oxygen demand in the heart.
by heart contractions to ensure an almost continuous flow of
oxygenated blood to the periphery (AlGhatrif and Lakatta, 2015).
Elastic arteries are therefore highly compliant, a property
not associated with smaller muscular arterioles (Marti et al.,
2012). Compliance is defined as the ability of an artery to
expand in response to pressure changes (Table 1). The degree of
elasticity is contingent upon three main factors: (1) differences
in elastin-to-collagen fiber ratios along the vessel, (2) differences
in endothelium-smooth muscle responses to cell stretch as a
result of stroke work, and (3) differences in sympathetic nerve
innervation affecting wall properties (Ooi et al., 2008; Steppan
et al., 2011; Marti et al., 2012; Zhipeng et al., 2014). Put simply,
compliance is the ability of a vessel to stretch, hold volume
and release it during the cardiac cycle. It is directly related to
distensibility and inversely related to stiffness (Table 1). The
more distal muscular arteries, such as the femoral artery, are
less distensible from having a lower elastin-to-collagen ratio
compared to the aorta (Zieman et al., 2005; Quinn et al., 2012).
Interestingly, arterial compliance and distensibility are inversely
related to heart rate, with a higher heart rate having a stiffening
effect on elastic arteries, and little effect on muscular arteries
(Mangoni et al., 1996). In addition, compliance is known to
influence coronary blood flow, an idea first proposed by Bouvrain
and Levy (1981).
THE ADENOSINE
VENTRICULAR-ARTERIAL (VA) COUPLING
HYPOTHESIS
In contrast to the relationship between myocardial adenosine
production and coronary artery perfusion, we propose a different
role for adenosine in the thoracic aorta. We propose that
adenosine may facilitate coupling between left ventricular output
and the ability of the arterial system to receive the blood
by modulating aortic compliance (Figures 2A,B). This transfer
function is termed ventricular-arterial (VA) coupling, and is the
ratio of arterial elastance to left-ventricular elastance (Table 1)
(Suga et al., 1993; Chen et al., 2001; Najjar et al., 2004;
Chantler et al., 2008; Guarracino et al., 2013). VA coupling has
consistently been shown to be a reliable and effective index
of cardiovascular performance to maintain oxygen supply to
respiring mitochondria (Najjar et al., 2004; Chantler et al., 2008;
Guarracino et al., 2013). When this coupling ratio is close to
unity, the efficiency of the system is considered to be optimal, and
during acute and chronic altered hemodynamic states, such as
low cardiac output, the ratio becomes less than one (Table 1). The
VA coupling ratio also reflects cardiac energetics, and the balance
betweenmyocardial oxygen consumption andmechanical energy
required to perform cardiac work (stroke work times heart rate)
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TABLE 1 | Definitions of key terms and methodologies.
Parameter Definition Physiological
significance
Compliance
(C) (ml ×
mmHg−1)
C = 1Blood Volume
1Blood Pressure An “index of elasticity” of
large conduit arteries.
Compliance is directly
related to “distensibility,”
and inversely related to
stiffness and elastance (see
Ea below). The endothelium
because of its capacity to
modulate smooth muscle
tone modulates compliance
Ventricular-
Arterial (VA)
Coupling
VA = Arterial ElastanceLV Elastance where
LV = Left ventricular
A measure of mechanical
efficiency of the
cardiovascular system from
assessing the interactions
between heart performance
and vascular function. When
Ea/Ees = 1.0, the efficiency
of the system is optimal
meaning that the left
ventricle is providing
sufficient SV at its lowest
possible myocardial energy
consumption. When Ea/Ees
< 1.0 (hypoxia, ischemia,
shock, sepsis, traumatic
brain injury) efficiency is
decreased
Arterial
Elastance (Ea)
Ea = ESP
SV
, mmHg/ml
ESP = LV end-systolic pressure
= [2 × (systolic BP + diastolic
BP)]/3 where BP is blood
pressure or ESP = 0.9 × systolic
BP SV, stroke volume 0.9 is a
factor that accounts for ESP
occurring slightly after peak
systolic BP
An arterial index that
estimates the capability of
the arterial vessels to
increase pressure when
stroke volume increases. Ea
is a measure of the total
arterial afterload on the
heart including arterial wall
stiffness, compliance and
outflow vascular resistance,
and systolic and diastolic
time intervals. Thus, Ea
lumps the steady and
pulsatile components of the
arterial load into a single
number
LV elastance
(Ees)
Ees = ESP
ESV
− Vo, mmHg/ml
ESP (see Ea above) ESV is LV
end-systolic volume Vo is x-axis
volume intercept of the
end-systolic P-V relationship
Ees is a load-independent
index of LV contractility.
Index also takes into
account stiffness,
compliance, fibrosis,
contraction synchrony and
geometric LV chamber
dimensions. Ees is an
integrated measure of LV
systolic performance to
pump blood into the arterial
tree and does not change
substantially with changes in
heart rate
Pulse wave
velocity (PWV)
Propagation speed of the wave
along the large arteries
PWV is inversely related with
BP, and is higher as arteries
become stiffer
(Continued)
TABLE 1 | Continued
VA-coupling Methodologies Comments and
references
Invasive
“Direct”
method
Left ventricular pressure-volume
(PV) loops. Ea (see above). Ees is
the slope of the end-systolic PV
relationship. End-systolic PV
relationship assumes
independent of load, and that
slope is linear
Suga et al., 1993; Chantler
et al., 2008; Guarracino
et al., 2013
Non-invasive
Method
Echocardiographic assessment
of LV end-diastolic and
end-systolic areas, and blood
pressures. Ea (see right). A single
beat measure of Ees is
calculated from ESP/ESV and
assumes Vo is zero
The non-invasive ESP
method for Ea or Ees
accurately predicts LV PV
loop measurements of ESP,
as does the ESP/ESV ratio
Chen et al., 2001; Najjar
et al., 2004; Chantler et al.,
2008; Guarracino et al.,
2013.
to propel blood forward to the periphery (Chen et al., 2001;
Najjar et al., 2004; Chantler et al., 2008; Guarracino et al.,
2013).
This new “compliance” role for adenosine may apply
to both beat-to-beat cycling during normal cardiac work
transitions and acute stress conditions such as during
ischemia, stroke, hemorrhagic shock, and other trauma
states (Figures 2A,B). In a porcine model of hemorrhagic
shock, Jonker and colleagues reported that the thoracic aorta
decreases in diameter by 40% and pulsatility decreases by
62% during blood loss compared to baseline (Jonker et al.,
2011).
In the thoracic aorta, adenosine may operate upstream of
other compliance regulators, such as NO (Ray and Marshall,
2006; Quillon et al., 2015). Endothelium-derived NO has
been shown to regulate the elastic properties of conduit
arteries, and wave profiles, by increasing vascular smooth
muscle relaxation (Wilkinson et al., 2002; Bellien et al., 2010;
Marti et al., 2012). We recently extended these studies and
showed that adenosine’s ability to dilate isolated rat thoracic
aortic rings involved endothelial NO and a complex interplay
between smooth muscle A2a subtype and voltage-dependent
Kv, SarcKATP, and MitoKATP channels (Arsyad and Dobson,
2016). A possible upstream scenario in the thoracic aorta is
that adenosine may bind to one or more endothelial G-protein
coupled receptors (e.g., A2A), increase cytosolic Ca
2+, activate
endothelial NO synthase and thereby produce NO. At the
same time, increased cytosolic Ca2+ may activate small- and
intermediate-conductance activated K+ channels to produce
endothelium-dependent membrane hyperpolarization (EDH)
(Félétou and Vanhoutte, 2007; Shimokawa and Godo, 2016;
Behringer, 2017). Adenosine, NO and EDHmay work in concert
to relax the underlying smooth muscle and increase arterial
compliance.
The cardiovascular significance of vasoactive drugs changing
smooth muscle tone of the elastic aorta was recognized by Bank
(1997) when he wrote:
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FIGURE 2 | (A) Schematic of adenosine’s ubiquitous distribution in the cardiovascular system. Adenosine receptors are coupled to G-proteins with diverse functions.
Adenosine is formed and released from most active cells when they are metabolically stressed. In the rat thoracic aorta all adenosine receptor subtypes are located in
the three layers of the vessel wall. The physiological significance of adenosine relaxation in large conduit arteries remains largely unknown. Data was obtained from the
literature (Fredholm et al., 2001; Tabrizchi and Bedi, 2001; Jacobson and Gao, 2006; Leal et al., 2008; Headrick et al., 2013; Minic et al., 2015). (B) The adenosine
Ventricular-Arterial (VA) coupling hypothesis proposes a link between adenosine, arterial compliance, stiffness and beat-to-beat coupling of cardiac systolic and
diastolic function during times of acute stress. Adenosine may increase compliance by decreasing tension in smooth muscle, and its associated series elastic
elements. When the heart ejects blood at a rate and volume that matches the capability of the arterial system to receive it, both cardiovascular performance and
cardiac energetics are believed to be optimal (VA coupling ratio = 1.0) (see Table 1).
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“Vasoactive drugs alter smooth muscle tone not only in arterial
resistance vessels, but also in large conduit arteries . . . The
resultant changes in smooth muscle tone alter both conduit vessel
size and stiffness and hence influence pulsatile components of left
ventricular afterload” (Bank, 1997).
Bank further reported that the effect to nitroglycerin, an NO
donor commonly used to treat myocardial ischemia in humans
by increasing coronary blood flow, also decreased pulse wave
velocity and increased arterial compliance from its dilation
properties and effects on heart chamber geometry (Bank and
Kaiser, 1998). In multicellular organisms, evolution may have
selected adenosine, nitric oxide and other modulators, to provide
optimal oxygen and nutrient transfer along vascular branching
networks from the lung, heart, large arteries and arterioles,
capillaries to respiring mitochondria (Dobson, 2003).
Additional support for the adenosine VA coupling hypothesis
comes from adenosine’s widespread distribution throughout the
cardiovascular system, and long recognized linkage between
transitioning from aerobic to anaerobic metabolism, AMP
production and adenosine formation (see Figure 2A). Since
adenosine has a very short half-life (secs), its ability to be
rapidly activate and inactivate may constitute a high-gain
feedback control system between the heart and conduit arteries.
Adenosine levels have been shown to change in heart muscle
during a single cardiac cycle, with higher levels being produced
during systole than diastole, indicating rapid metabolism of
adenosine (Thompson et al., 1980). In addition, adenosine
depresses heart pacemaker activity (negative chronotropic effect),
decreases atrial and ventricle contractility (negative inotropic
effect), depresses cardiac automaticity (dromotropic effect), and
decreases heart diastolic stiffness (lusitropic effect) (Figure 2A)
(Vinten-Johansen et al., 1999; Jacobson and Gao, 2006; Mustafa
et al., 2009; Headrick et al., 2013; Minic et al., 2015).
Perhaps the most compelling set of human data supporting
a role for adenosine in VA coupling comes from Wong and
colleagues who reported a relationship between increased aortic
stiffness, lower VA coupling and lower coronary blood flow
in patients with stable angina undergoing an adenosine stress
test (Wong et al., 2010). Unfortunately, these authors did
not comment on a possible adenosine spatial-temporal link
between arterial stiffness and coronary perfusion, presumably
because it was a clinical diagnostic test. Leung and colleagues
also showed in humans that aortic stiffness affected coronary
blood flow during percutaneous coronary intervention (PCI),
and that a more compliant aorta was associated with a greater
improvement in adenosine-induced increases in coronary blood
flow compared to patients which had a stiffer aorta (Leung
et al., 2006). Pagliaro and colleagues also showed in dogs
that a combination of low dose adenosine and enhanced
perfusion pulsatility markedly increased coronary blood flow
by mechanisms involving adenosine receptors, NO and KATP
channels, and possibly other purinergic receptors (Pagliaro et al.,
1999; Kass, 2005; Burnstock and Ralevic, 2013). Adenosine has
also been reported to dilate the vasa vasorum that supplies
blood to the aortic media (Heistad et al., 1978), which may
also influence compliance. Future studies are required to extend
these clinical and experimental observations, and examine if the
effects of adenosine (and NO) in large elastic arteries change
in concentration under different cardiac workload conditions.
If changes are found they may reflect differential activation of
adenosine receptor subtypes (A1, A2A, A2B, and A3) (Figure 2A).
Interestingly, Leal and colleagues reported that the rat abdominal
aorta had 35-times higher abundance of the A3 receptor subtype
than in amuscular tail artery, and a significantly lower abundance
of A1 and A2A receptors in the conduit (Leal et al., 2008), which
may imply different functional roles (Figures 2A,B).
Finally, since the heart and elastic and geometric properties
of conduit arteries are important predictors of aging and
disease progression, the adenosine VA hypothesis may offer
a new conceptual scheme for future research and therapeutic
intervention. Questions include whether adenosine levels change
in large conduit arteries and along their length in healthy vs. older
patients with hypertension, diabetes mellitus, obesity, coronary
artery disease and/or heart failure (AlGhatrif and Lakatta, 2015;
Yurdagul et al., 2016). Further, do these changes correlate with
changes in myocardial perfusion, VA coupling and wall stiffness?
Indeed, progressive vessel wall stiffening, and microcirculatory
endothelial dysfunction has been reported along the wall of
the thoracic aorta, which precedes hypertension, diabetes and
cardiovascular diseases, including aortic aneurysms (Erbel and
Eggebrecht, 2006; Huveneers et al., 2015). Recently the VA
coupling ratio was found to be profoundly decreased in a
population of centenarians without overt cardiovascular disease,
particularly in women (Sonaglioni et al., 2017), highlighting again
the importance of understanding the changes between heart,
aortic compliance and vascular aging. In conclusion, we propose
that adenosine may play an important role in maintaining
aortic wall integrity and compliance for optimal VA coupling,
coronary perfusion and downstream regulation of tissue
blood flow and oxygenation. This hypothesis warrants further
testing.
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